In the Reset Your Set Point program, a physician may prescribe patients tirzepatide compounded with B-12 and dispensed in a vial that allows for flexible dosing.
The cost of tirzepatide starts at $275 for a 6-week supply.
Tirzepatide is a GLP-1 receptor agonist and GIP (glucose-dependent insulinotropic polypeptide) receptor. It is commonly known by the brand names Mounjaro which is FDA approved for type 2 diabetes and Zepbound which is FDA approved for weight loss. It is taken as a weekly subcutaneous injection.
In clinical trials, the manufacturer of Mounjaro showed that patients taking tirzepatide in a 68-week study had weight loss results of 26%
of their starting body weight.
The most common side effects of tirzepatide include nausea, diarrhea, and constipation, which typically lessen over time.
To learn if you might be eligible for weight loss treatment with tirzepatide, take our quick online assessment